Multimorbidity Signs and Symptoms Multimorbidity
Conditions
Interventions
When a participant agrees to take part in the trial they will be randomly assigned to the intervention or waiting list control group using random permuted blocks to ensure groups are balanced. The ran
the phone calls are not part of the treatment regimen. Adherence to the intervention will be remotely monitored. If a participant wishes to discontinue their involvement they will be withdrawn from th
Sponsors
Health Research Board
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Current inclusion criteria as of 15/02/2018: 1. Aged 18 years or over 2. Presence of chronic pain and at least one other chronic conditions reported by the patient as having been diagnosed by a doctor 3. Resident of the Republic of Ireland 4. Access to a computer and the internet 5. Not currently undergoing any form of psychological treatment 6. Sufficiently competent in the English language (as determined by the participant) to complete the various elements of the study 7. Provision of informed consent Previous inclusion criteria: 1. Aged 18 years or over 2. Presence of two or more chronic conditions reported by the patient as having been diagnosed by a doctor 3. Resident of the Republic of Ireland 4. Access to a computer and the internet 5. Not currently undergoing any form of psychological treatment 6. Sufficiently competent in the English language (as determined by the participant) to complete the various elements of the study 7. Provision of informed consent
Exclusion criteria
Exclusion criteria: Not fulfilling the inclusion criteria.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Current primary outcome measures as of 15/02/2018: Health related quality of life will be measured using the EQ-5D and pain interference will be measured using the Brief Pain Inventory. Both measures will be administered at baseline, post-intervention (week 8) and three months post-intervention. Previous primary outcome measures: Health related quality of life will be measured using the SF-36 and will be administered at baseline, post-intervention (week 8) and three months post-intervention. | — |
Secondary
| Measure | Time frame |
|---|---|
| Current secondary outcome measures as of 15/02/2018: 1. Global improvement with treatment is measured using the Patient Global Impression of Change Scale at baseline, post-intervention (week 8) and three months post-intervention. 2. Psychological inflexibility and experiential avoidance is measured using The Acceptance and Action Questionnaire II at baseline, post-intervention (week 8) and three months post-intervention. 3. Patient illness perceptions in the presence of multimorbidity is measured using The Multimorbidity Illness Perceptions Scale at baseline, post-intervention (week 8) and three months post-intervention. 4. Depression is measured using the Patient Health Questionnaire at baseline, post-intervention (week 8) and three months post-intervention. 5. Anxiety is measured using the Generalized Anxiety Disorder 7-item (GAD-7) scale at baseline, post-intervention (week 8) and three months post-intervention. 6. Health Care Use is measured using the Client Services Receipt Inventory a baseline, post-intervention (week 8) and three months post-intervention. Previous secondary outcome measures: 1. Global improvement with treatment is measured using the Patient Global Impression of Change Scale at baseline, post-intervention (week 8) and three months post-intervention 2. Psychological inflexibility and experiential avoidance is measured using The Acceptance and Action Questionnaire II at baseline, post-intervention (week 8) and three months post-intervention 3. Patient illness perceptions in the presence of multimorbidity is measured using The Multimorbidity Illness Perceptions Scale at baseline, post-intervention (week 8) and three months post-intervention 4. Depression is measured using the Patient Health Questionnaire at baseline, post-intervention (week 8) and three months post-interve | — |
Countries
Ireland
Contacts
Public ContactBrian Slattery
Outcome results
None listed